Arbor Research Collaborative for Health serves as a trusted research partner in the healthcare sector, providing advanced research, analysis, and real-world evidence services to pharmaceutical, biotech, and life science companies [5]. The organization operates through a dual structure consisting of its nonprofit entity and LLC subsidiary, both offering specialized services through GSA Multiple Award Schedule contracts [6].
Leadership and Governance The organization maintains a robust leadership structure guided by experienced professionals:
- Marianne Udow-Phillips, MHSA - Board Chair
- Akinlolu Ojo, MD, MPH, PhD, MBA - Board Vice-Chair
- Christopher Spera, PhD - Board President
- Richard Pietroski, MS - Board Treasurer
- Larry Warren, MS - Board Secretary [2]
- Chauncey Lynch, BS - Vice President of Finance & Chief Financial Officer
- Shanthy Edward, M.A., Psy.D. - Vice President of Strategic Growth & Chief Growth Officer [3]
Core Services and Partnerships Arbor Research delivers comprehensive healthcare research services while maintaining significant partnerships with industry leaders. Their service portfolio includes:
- Real-world evidence generation
- Regulatory submission support
- Market access strategy development
- Post-marketing surveillance [5]
- Major pharmaceuticals (AstraZeneca, GlaxoSmithKline, Merck)
- Biotechnology firms (Amgen, Baxter Healthcare)
- Healthcare service providers (United HealthCare Services)
- Specialty medical companies (Outset Medical, Somatus) [5]
- Arbor Research Collaborative for Health: Contract #47QRAA22D008J
- Arbor Research, LLC: Contract #47QRAA24D00BA (Small Business) [1]
- Agency for Healthcare Research and Quality (AHRQ)
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare & Medicaid Services (CMS)
- Federal Emergency Management Agency (FEMA)
- Health Resources and Services Administration (HRSA)
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [3]
- Selection as one of 14 organizations to lead the OPTN modernization [2]
- National Cancer Institute Center for Global Health contract award [1]
- Launch of PARADIGM, a European CKD-aP Treatment Registry [6]
- Partnership with NANI for CKD management research [7]
The organization maintains a culture focused on innovation and excellence, encouraging employees to demonstrate initiative, ingenuity, and intellectual curiosity in pursuit of improved healthcare outcomes [7].